# French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

> **NCT05308927** · — · ENROLLING_BY_INVITATION · sponsor: **Novo Nordisk A/S** · enrollment: 221 (estimated)

## Conditions studied

- Noonan Syndrome

## Interventions

- **DRUG:** Norditropin

## Key facts

- **NCT ID:** NCT05308927
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-03-16
- **Primary completion:** 2028-03-17
- **Final completion:** 2028-03-17
- **Target enrollment:** 221 (ESTIMATED)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05308927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05308927, "French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05308927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*